Paul Tudor Jones Amarin Corp Plcuk Transaction History

Tudor Investment Corp Et Al

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.13 - $3.69 $11,400 - $37,228	-10,089 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $28,753 - $37,631	10,089 New	10,089 $33,000
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $137,468 - $293,064	-37,766 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $180,521 - $311,947	37,766 New	37,766 $261,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $164,568 - $885,787	-41,142 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $573,519 - $992,345	41,142 New	41,142 $882,000
Q2 2018 Aug 14, 2018	SELL	$2.68 - $3.48 $52,517 - $68,194	-19,596 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $25,116 - $37,296	8,400 Added 75.03%	19,596 $59,000
Q4 2017 Feb 14, 2018	SELL	$3.06 - $4.09 $21 - $28	-7 Reduced 0.06%	11,196 $45,000
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $33,945 - $41,675	11,203	11,203 $39,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $181M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.